The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development
A
Arielle Elkrief
R
Reilly Pidgeon
S
Saman Maleki Vareki
M
Meriem Messaoudene
B
Bastien Castagner
B
Bertrand Routy
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 24, Issue 9
Published
September 01, 2025
Pages
685-704
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (6)
A
Arielle Elkrief
R
Reilly Pidgeon
S
Saman Maleki Vareki
M
Meriem Messaoudene
B
Bastien Castagner
B
Bertrand Routy
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w